-
1
-
-
70949107842
-
Inflammatory bowel disease
-
C. Abraham, and J.H. Cho Inflammatory bowel disease N Engl J Med 361 2009 2066 2078
-
(2009)
N Engl J Med
, vol.361
, pp. 2066-2078
-
-
Abraham, C.1
Cho, J.H.2
-
2
-
-
83755219473
-
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review
-
quiz e30 e42
-
N.A. Molodecky, I.S. Soon, D.M. Rabi, and et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review Gastroenterology 142 2012 46 54 e42 quiz e30
-
(2012)
Gastroenterology
, vol.142
, pp. 46-54
-
-
Molodecky, N.A.1
Soon, I.S.2
Rabi, D.M.3
-
3
-
-
84868336049
-
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
-
L. Jostins, S. Ripke, R.K. Weersma, and et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease Nature 491 2012 119 124
-
(2012)
Nature
, vol.491
, pp. 119-124
-
-
Jostins, L.1
Ripke, S.2
Weersma, R.K.3
-
4
-
-
57449118239
-
Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense
-
N. Satoh-Takayama, C.A. Vosshenrich, S. Lesjean-Pottier, and et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense Immunity 29 2008 958 970
-
(2008)
Immunity
, vol.29
, pp. 958-970
-
-
Satoh-Takayama, N.1
Vosshenrich, C.A.2
Lesjean-Pottier, S.3
-
5
-
-
78751706261
-
CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut
-
G.F. Sonnenberg, L.A. Monticelli, M.M. Elloso, and et al. CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut Immunity 34 2011 122 134
-
(2011)
Immunity
, vol.34
, pp. 122-134
-
-
Sonnenberg, G.F.1
Monticelli, L.A.2
Elloso, M.M.3
-
6
-
-
77951878587
-
Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology
-
S. Buonocore, P.P. Ahern, H.H. Uhlig, and et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology Nature 464 2010 1371 1375
-
(2010)
Nature
, vol.464
, pp. 1371-1375
-
-
Buonocore, S.1
Ahern, P.P.2
Uhlig, H.H.3
-
7
-
-
84867856710
-
The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells
-
N. Powell, A.W. Walker, E. Stolarczyk, and et al. The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells Immunity 37 2012 674 684
-
(2012)
Immunity
, vol.37
, pp. 674-684
-
-
Powell, N.1
Walker, A.W.2
Stolarczyk, E.3
-
8
-
-
60549102720
-
Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22
-
H. Takatori, Y. Kanno, W.T. Watford, and et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22 J Exp Med 206 2009 35 41
-
(2009)
J Exp Med
, vol.206
, pp. 35-41
-
-
Takatori, H.1
Kanno, Y.2
Watford, W.T.3
-
9
-
-
84872977452
-
Innate lymphoid cells - A proposal for uniform nomenclature
-
H. Spits, D. Artis, M. Colonna, and et al. Innate lymphoid cells - A proposal for uniform nomenclature Nat Rev Immunol 13 2013 145 149
-
(2013)
Nat Rev Immunol
, vol.13
, pp. 145-149
-
-
Spits, H.1
Artis, D.2
Colonna, M.3
-
10
-
-
34848889673
-
Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system
-
W.S. Garrett, G.M. Lord, S. Punit, and et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system Cell 131 2007 33 45
-
(2007)
Cell
, vol.131
, pp. 33-45
-
-
Garrett, W.S.1
Lord, G.M.2
Punit, S.3
-
11
-
-
69249232549
-
Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells
-
W.S. Garrett, S. Punit, C.A. Gallini, and et al. Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells Cancer Cell 16 2009 208 219
-
(2009)
Cancer Cell
, vol.16
, pp. 208-219
-
-
Garrett, W.S.1
Punit, S.2
Gallini, C.A.3
-
12
-
-
79958277385
-
IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease
-
A. Geremia, C.V. Arancibia-Carcamo, M.P. Fleming, and et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease J Exp Med 208 2011 1127 1133
-
(2011)
J Exp Med
, vol.208
, pp. 1127-1133
-
-
Geremia, A.1
Arancibia-Carcamo, C.V.2
Fleming, M.P.3
-
13
-
-
85027945857
-
Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues
-
J.H. Bernink, C.P. Peters, M. Munneke, and et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues Nat Immunol 14 2013 221 229
-
(2013)
Nat Immunol
, vol.14
, pp. 221-229
-
-
Bernink, J.H.1
Peters, C.P.2
Munneke, M.3
-
14
-
-
84876780238
-
Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells
-
A. Fuchs, W. Vermi, J.S. Lee, and et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells Immunity 38 2013 769 781
-
(2013)
Immunity
, vol.38
, pp. 769-781
-
-
Fuchs, A.1
Vermi, W.2
Lee, J.S.3
-
15
-
-
84929663292
-
The unusual suspects - Innate lymphoid cells: Novel therapeutic targets in IBD
-
R. Goldberg, N. Prescott, G.M. Lord, and et al. The unusual suspects - innate lymphoid cells: novel therapeutic targets in IBD Nat Rev Gastroenterol Hepatol 12 2015 271 283
-
(2015)
Nat Rev Gastroenterol Hepatol
, vol.12
, pp. 271-283
-
-
Goldberg, R.1
Prescott, N.2
Lord, G.M.3
-
16
-
-
84866362664
-
IL-1beta mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells
-
M. Coccia, O.J. Harrison, C. Schiering, and et al. IL-1beta mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells J Exp Med 209 2012 1595 1609
-
(2012)
J Exp Med
, vol.209
, pp. 1595-1609
-
-
Coccia, M.1
Harrison, O.J.2
Schiering, C.3
-
17
-
-
84903442371
-
Nod/Ripk2 signaling in dendritic cells activates IL-17A-secreting innate lymphoid cells and drives colitis in T-bet-/-.Rag2-/- (TRUC) mice
-
J. Ermann, T. Staton, J.N. Glickman, and et al. Nod/Ripk2 signaling in dendritic cells activates IL-17A-secreting innate lymphoid cells and drives colitis in T-bet-/-.Rag2-/- (TRUC) mice Proc Natl Acad Sci U S A 111 2014 E2559 E2566
-
(2014)
Proc Natl Acad Sci U S A
, vol.111
, pp. E2559-E2566
-
-
Ermann, J.1
Staton, T.2
Glickman, J.N.3
-
18
-
-
72549107316
-
Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease
-
L. Rovedatti, T. Kudo, P. Biancheri, and et al. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease Gut 58 2009 1629 1636
-
(2009)
Gut
, vol.58
, pp. 1629-1636
-
-
Rovedatti, L.1
Kudo, T.2
Biancheri, P.3
-
19
-
-
9144231336
-
Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation
-
K. Brocke-Heidrich, A.K. Kretzschmar, G. Pfeifer, and et al. Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation Blood 103 2004 242 251
-
(2004)
Blood
, vol.103
, pp. 242-251
-
-
Brocke-Heidrich, K.1
Kretzschmar, A.K.2
Pfeifer, G.3
-
20
-
-
84876806691
-
Dynamic regulatory network controlling TH17 cell differentiation
-
N. Yosef, A.K. Shalek, J.T. Gaublomme, and et al. Dynamic regulatory network controlling TH17 cell differentiation Nature 496 2013 461 468
-
(2013)
Nature
, vol.496
, pp. 461-468
-
-
Yosef, N.1
Shalek, A.K.2
Gaublomme, J.T.3
-
21
-
-
45549097533
-
IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens
-
S.M. Dann, M.E. Spehlmann, D.C. Hammond, and et al. IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens J Immunol 180 2008 6816 6826
-
(2008)
J Immunol
, vol.180
, pp. 6816-6826
-
-
Dann, S.M.1
Spehlmann, M.E.2
Hammond, D.C.3
-
22
-
-
84873729246
-
A T-bet gradient controls the fate and function of CCR6-RORgammat+ innate lymphoid cells
-
C.S. Klose, E.A. Kiss, V. Schwierzeck, and et al. A T-bet gradient controls the fate and function of CCR6-RORgammat+ innate lymphoid cells Nature 494 2013 261 265
-
(2013)
Nature
, vol.494
, pp. 261-265
-
-
Klose, C.S.1
Kiss, E.A.2
Schwierzeck, V.3
-
23
-
-
0027451455
-
Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease
-
H.C. Reinecker, M. Steffen, T. Witthoeft, and et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease Clin Exp Immunol 94 1993 174 181
-
(1993)
Clin Exp Immunol
, vol.94
, pp. 174-181
-
-
Reinecker, H.C.1
Steffen, M.2
Witthoeft, T.3
-
24
-
-
0025599882
-
Significant increase of interleukin 6 production in blood mononuclear leukocytes obtained from patients with active inflammatory bowel disease
-
Y. Suzuki, H. Saito, J. Kasanuki, and et al. Significant increase of interleukin 6 production in blood mononuclear leukocytes obtained from patients with active inflammatory bowel disease Life Sci 47 1990 2193 2197
-
(1990)
Life Sci
, vol.47
, pp. 2193-2197
-
-
Suzuki, Y.1
Saito, H.2
Kasanuki, J.3
-
25
-
-
0027313034
-
Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease
-
J.S. Hyams, J.E. Fitzgerald, W.R. Treem, and et al. Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease Gastroenterology 104 1993 1285 1292
-
(1993)
Gastroenterology
, vol.104
, pp. 1285-1292
-
-
Hyams, J.S.1
Fitzgerald, J.E.2
Treem, W.R.3
-
26
-
-
76149132672
-
Early-onset Crohn disease is associated with male sex and a polymorphism in the IL-6 promoter
-
K. Sagiv-Friedgut, A. Karban, B. Weiss, and et al. Early-onset Crohn disease is associated with male sex and a polymorphism in the IL-6 promoter J Pediatr Gastroenterol Nutr 50 2010 22 26
-
(2010)
J Pediatr Gastroenterol Nutr
, vol.50
, pp. 22-26
-
-
Sagiv-Friedgut, K.1
Karban, A.2
Weiss, B.3
-
27
-
-
10044264634
-
Pivotal roles of interleukin-6 in transmural inflammation in murine T cell transfer colitis
-
K. Kitamura, Y. Nakamoto, S. Kaneko, and et al. Pivotal roles of interleukin-6 in transmural inflammation in murine T cell transfer colitis J Leukoc Biol 76 2004 1111 1117
-
(2004)
J Leukoc Biol
, vol.76
, pp. 1111-1117
-
-
Kitamura, K.1
Nakamoto, Y.2
Kaneko, S.3
-
28
-
-
16644392805
-
Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice
-
Y. Naito, T. Takagi, K. Uchiyama, and et al. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice Int J Mol Med 14 2004 191 196
-
(2004)
Int J Mol Med
, vol.14
, pp. 191-196
-
-
Naito, Y.1
Takagi, T.2
Uchiyama, K.3
-
29
-
-
33747774200
-
STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice
-
K. Mitsuyama, S. Matsumoto, S. Rose-John, and et al. STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice Gut 55 2006 1263 1269
-
(2006)
Gut
, vol.55
, pp. 1263-1269
-
-
Mitsuyama, K.1
Matsumoto, S.2
Rose-John, S.3
-
30
-
-
18344410191
-
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo
-
R. Atreya, J. Mudter, S. Finotto, and et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo Nat Med 6 2000 583 588
-
(2000)
Nat Med
, vol.6
, pp. 583-588
-
-
Atreya, R.1
Mudter, J.2
Finotto, S.3
-
31
-
-
84355162720
-
Priming microenvironments dictate cytokine requirements for T helper 17 cell lineage commitment
-
W. Hu, T.D. Troutman, R. Edukulla, and et al. Priming microenvironments dictate cytokine requirements for T helper 17 cell lineage commitment Immunity 35 2011 1010 1022
-
(2011)
Immunity
, vol.35
, pp. 1010-1022
-
-
Hu, W.1
Troutman, T.D.2
Edukulla, R.3
-
32
-
-
45749107055
-
Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis
-
N. Kamada, T. Hisamatsu, S. Okamoto, and et al. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis J Clin Invest 118 2008 2269 2280
-
(2008)
J Clin Invest
, vol.118
, pp. 2269-2280
-
-
Kamada, N.1
Hisamatsu, T.2
Okamoto, S.3
-
33
-
-
30944466824
-
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach
-
C. Manichanh, L. Rigottier-Gois, E. Bonnaud, and et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach Gut 55 2006 205 211
-
(2006)
Gut
, vol.55
, pp. 205-211
-
-
Manichanh, C.1
Rigottier-Gois, L.2
Bonnaud, E.3
-
34
-
-
2342442430
-
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease
-
S.J. Ott, M. Musfeldt, D.F. Wenderoth, and et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease Gut 53 2004 685 693
-
(2004)
Gut
, vol.53
, pp. 685-693
-
-
Ott, S.J.1
Musfeldt, M.2
Wenderoth, D.F.3
-
35
-
-
40749114497
-
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): A double-blind, placebo-controlled, randomised trial
-
J.S. Smolen, A. Beaulieu, A. Rubbert-Roth, and et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial Lancet 371 2008 987 997
-
(2008)
Lancet
, vol.371
, pp. 987-997
-
-
Smolen, J.S.1
Beaulieu, A.2
Rubbert-Roth, A.3
-
36
-
-
40749152243
-
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: A randomised, double-blind, placebo-controlled, withdrawal phase III trial
-
S. Yokota, T. Imagawa, M. Mori, and et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial Lancet 371 2008 998 1006
-
(2008)
Lancet
, vol.371
, pp. 998-1006
-
-
Yokota, S.1
Imagawa, T.2
Mori, M.3
-
37
-
-
75749113331
-
Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase i dosage-escalation study
-
G.G. Illei, Y. Shirota, C.H. Yarboro, and et al. Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study Arthritis Rheum 62 2010 542 552
-
(2010)
Arthritis Rheum
, vol.62
, pp. 542-552
-
-
Illei, G.G.1
Shirota, Y.2
Yarboro, C.H.3
-
38
-
-
11144358366
-
A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease
-
discussion 947
-
H. Ito, M. Takazoe, Y. Fukuda, and et al. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease Gastroenterology 126 2004 989 996 discussion 947
-
(2004)
Gastroenterology
, vol.126
, pp. 989-996
-
-
Ito, H.1
Takazoe, M.2
Fukuda, Y.3
-
39
-
-
84886947164
-
The challenges of stratifying patients for trials in inflammatory bowel disease
-
P. Biancheri, N. Powell, G. Monteleone, and et al. The challenges of stratifying patients for trials in inflammatory bowel disease Trends Immunol 34 2013 564 571
-
(2013)
Trends Immunol
, vol.34
, pp. 564-571
-
-
Biancheri, P.1
Powell, N.2
Monteleone, G.3
-
40
-
-
84884251320
-
Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform
-
J.J. Kozich, S.L. Westcott, N.T. Baxter, and et al. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform Appl Environ Microbiol 79 2013 5112 5120
-
(2013)
Appl Environ Microbiol
, vol.79
, pp. 5112-5120
-
-
Kozich, J.J.1
Westcott, S.L.2
Baxter, N.T.3
-
42
-
-
66249145772
-
Statistical methods for detecting differentially abundant features in clinical metagenomic samples
-
J.R. White, N. Nagarajan, and M. Pop Statistical methods for detecting differentially abundant features in clinical metagenomic samples PLoS Comp Biol 5 2009 e1000352
-
(2009)
PLoS Comp Biol
, vol.5
, pp. e1000352
-
-
White, J.R.1
Nagarajan, N.2
Pop, M.3
-
43
-
-
79960004119
-
Interactive tree of life v2: Online annotation and display of phylogenetic trees made easy
-
I. Letunic, and P. Bork Interactive tree of life v2: online annotation and display of phylogenetic trees made easy Nucleic Acids Res 39 2011 W475 W478
-
(2011)
Nucleic Acids Res
, vol.39
, pp. W475-W478
-
-
Letunic, I.1
Bork, P.2
|